Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancing Relapse Prevention With rTMS: Dose-Response Parameters for Smoking Cessation

NCT03865472 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.

NCT NCT03865472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03865472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancing Relapse Prevention With rTMS: Dose-Response Parameters for Smoking Cessation
Lead sponsor
Roswell Park Cancer Institute
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 10, 2018
Completion date
November 13, 2026
Enrollment
206 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cigarette smoker, current every day smoker, current smoker